Vulcan Energy: A Sector-Wide Selloff, a Seventh Well, and a Plant Making Adsorbent Rather Than Lithium

Vulcan Energy's share price has been moving to a rhythm set well outside its own drilling programme. The stock was down 2.3% in pre-market trading on the day covered by the latest reports, and the wider context is a broad selloff in Australian lithium equities that media coverage dated 13 October placed Vulcan among the hardest-hit names. That pressure has a dual origin: softening lithium prices and a proposed EU cap that would limit imports of Chinese hybrid vehicles to 350,000 units a year.

None of that is specific to Vulcan. The selling wave swept across a number of companies in the sector, which matters for how the share price should be read. A sector story describes the market environment; the Lionheart news describes engineering progress. Both can be true at once — a company can advance a project while investors take a dimmer view of the whole industry — so the day's move is not a verdict on any single project milestone.

What the drill test actually showed

The most concrete data point Vulcan has offered recently came on a Thursday, when it reported a measured surface injection rate of roughly 35 sL/s for well LSC-3a. From that figure the company derived an injection capacity of about 64 sL/s for the intended operating conditions, against a planning assumption of some 40 sL/s.

The gap between those numbers is where the care is needed. The 64 sL/s is an estimate extrapolated for planned operating conditions, not a rate measured at the surface, and not production or extraction output. Vulcan read the data as confirmation of matrix reinjection. LSC-3a is the seventh hole in a Lionheart field development plan designed around 28 wells, so the result covers one component of a much larger undertaking; its value lies in the technical confirmation of the reinjection concept, not in any statement about completion of the development plan.

The German plant is making the extraction medium, not the lithium

Roughly a month before that drilling update, Vulcan began commercial production of its own lithium extraction adsorbent, VULSORB, in Germany. The output is destined for Lionheart, where it will supply the initial fill of the extraction columns.

That distinction is easy to blur. Vulcan is manufacturing a material the future lithium operation will need; the announcement does not mark the start of lithium production at Lionheart. It is an upstream step in preparing for the planned commissioning, which remains scheduled for the second half of 2028. For investors, the line to hold is between confirmed development steps and a project start that has not yet happened.

The previously reported reinjection test fits the same pattern. According to the company it underpins a central assumption of the base development plan and, in Vulcan's view, provides a foundation for further optimisation.

Two clocks running at different speeds

The next fixed reference point on the calendar is the September quarterly report, due on 28 October 2026. It will be the next scheduled anchor for judging how the project is progressing.

Until then, the picture splits in two. Company announcements document advances in individual building blocks — VULSORB preparing the first column fill, the well test supporting the technical plan — and together they show preparation moving forward, without any earlier start of operations being announced. The pressure on lithium equities, meanwhile, sets the broader valuation framework. Technical confirmation and a friendlier market are separate prerequisites; project wins so far do not substitute for relief at the sector level.